VTCRC tenant Skyphos Technologies is a biotech and advanced manufacturing company that solves a decades-long manufacturing gap for next-generation medical diagnostics and lab-on-a-chip components, getting cures off the lab bench and to the patient bedside. Check out this webinar to learn more.
The latest advantages of utilizing 3D printing for the fabrication of microfluidic devices and organ-on-a-chip systems have opened up new horizons in biomedical research and personalized medicine. 3D printing offers precision and flexibility that traditional methods often cannot achieve, enabling the rapid and cost-effective production of intricate microscale structures that mimic the complexity of human organs and tissue environments. Researchers can now customize microfluidic devices to emulate specific physiological conditions, allowing for more accurate drug testing and disease modeling. Moreover, the ability to integrate multiple materials in a single print enables the recreation of tissue interfaces and vascular networks, fostering the development of more lifelike organ-on-a-chip platforms. This innovative approach promises to revolutionize drug development, toxicology testing, and disease understanding, offering a glimpse into a future where personalized medicine is driven by these advanced, 3D-printed microsystems. In this upcoming virtual event, 3DHEALS invites you to join world-class panelists and entrepreneurs to explore the future of this promising application together.
#3dprinting#Benchtobedside#medicaldiagnostics#science#technology#VTCRC#blacksburg